Abstract
We identified a mutation in the ceruloplasmin (Cp) gene in a Japanese family with aceruloplasminemia, some of whose members showed extrapyramidal disorders, cerebellar ataxia, and diabetes mellitus. A post–mortem study of the proband revealed excessive iron deposition mainly in the brain, liver and pancreas. The G to A transition at the splice acceptor site introduces a premature termination codon at the amino acid position 991 by defective splicing, thereby truncating the carboxyl terminus of Cp in affected individuals. We conclude that the mutation in the Cp gene is associated with systemic hemosiderosis in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Poulik, M.D. & Weiss, M.L. Ceruloplasmin. The Plasma Proteins Vol II (ed. Putnam, F.W.) 51–108 (Academic, New York, 1975).
Frieden, E. Ceruloplasmin: a multifunctional metalloprotein of vertebrate plasma. Metal Ions in Biological Systems Vol 13 (ed. Sigel, H.) 117–142 (Marcel Dekker, New York, 1961).
Cousins, R.J. orption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and Ceruloplasmin. Physiol. Rev. 65, 238–309 (1985).
Takahashi, N., Ortel, T.L. & Putnam, F.W. Single-chain structure of human Ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc. natn. Acad. Sci. U.S.A. 81, 390–394 (1984).
Dwulet, F.E. & Putnam, F.W. Internal duplication and evolution of human Ceruloplasmin. Proc. natn. Acad. Sci. U.S.A 78, 2805–2809 (1981).
Takahashi, N., Bauman, R.A., Ortel, T.L., Dwulet, F.E., Wang, C.-C. & Putnam, F.W. Internal triplication in the structure of human Ceruloplasmin. Proc. natn. Acad. Sci. U.S.A. 80, 115–119 (1983).
Ortel, T.L., Takahashi, N. & Putnam, F.W. Structural model of human Ceruloplasmin based on internal triplication, hydrophllic/hydrophoblc character, and secondary structure of domains. Proc. natn. Acad. Sci. U.S.A. 81, 4761–4765 (1984).
Koschinsky, M.L., Funk, W.D., van Cost, B.A. & MacGillivray, R.T.A. Complete cDNA sequence of human preceruloplasmin. Proc. natn. Acad. Sci. U.S.A. 83, 5086–6090 (1986).
Yang, F. et al. Characterization, mapping, and expression of the human Ceruloplasmin gene. Proc. natn. Acad. Sci. U.S.A. 83, 3257–3261 (1986).
Mercer, J.F.B. & Grimes, A. Isolation of a human Ceruloplasmin cDNA clone that includes the N-terminal leader sequence. FEBS Letts. 203, 185–190 (1986).
Danks, D.M. Disorders of copper transport. The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 1411–1431 (McGraw-Hill, New York, 1989).
Vulpe, C., Levlnson, B., Whitney, S., Packman, S. & Gitschier, J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper- transporting ATPase. Nature Genet. 3, 7–13 (1993).
Chelly, J. et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nature Genet. 3, 14–19 (1993).
Mercer, J.F.B. et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet. 3, 20–25 (1993).
Bull, P.C., Thomas, G.R., Rommens, J.M., Forbes, J.R. & Cox, D.W. The Wilson disease gene is a putative copper transporting P-type ATP ase similar to the Menkes gene. Nature Genet. 5, 327–337 (1993).
Petrukhin, K. et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nature Genet. 5, 338–343 (1993).
Tanzl, R.E. et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet. 5, 344–350 (1993).
Yamaguchi, Y., Helny, M.E. & Gitlin, J.D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem. biophys. Res. Commun. 197, 271–277 (1993).
Miyajima, H. et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37, 761–767 (1987).
Morita, H., Inoue, A. & Yanagisawa, N. A case with Ceruloplasmin deficiency which showed dementia, ataxiaand Iron deposition in the brain. (in Japanese) Clin. Neurol. (Tokyo) 32, 483–487 (1992).
Logan, I., Harueyson, K.B., Wilsdom, G.B., Hughes, A.E. & Archbold, P.R. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q. J. Med. 87, 663–670 (1994).
Morita, H. et al. Hereditary Ceruloplasmin deficiency with hemosiderosls: a clinicopathological study of a Japanese family. Ann. Neurol. (In the press).
Dancis, A. et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper In Iron transport. Cell 76, 393–402 (1994).
Askwith, C. et al. The FET3 gene of S. cerevisiae encodes a multlcopper oxidase required for ferrous Iron uptake. Cell 76, 403–410 (1994).
Hiyamuta, S. & Takeichi, N. Lack of copper binding sites in Ceruloplasmin of LEC rats with abnormal copper metabolism. Biochem. Biophys. Res Commun. 197, 1140–1145 (1993).
Hiyamuta, S. & Ito, K. Monoclonal antibody against the active site of caeruloplasmin and the ELJSA system detecting active caeruloplasmin. Hybridoma 13, 139–141 (1994).
Koschinsky, M.L., Chow, B.K.-C., Schwartz, J., Hamerton, J.L. & MacGillivray, R.T.A. Isolation and characterization of a processed gene for human Ceruloplasmin. Biochemistry 26, 7760–7767 (1987).
Garey, C.E., Schwarzman, A.L., Rise, M.L. & Seyfried, T.N. Ceruloplasmin gene defect associated with epilepsy in EL mice. Nature Genet. 6, 426–431 (1994).
Daar, I.O. & Maquat, L.E. Premature translation termination mediates triosephosphate isomerase mRNA degradation. Molec. Cell. Biol. 8, 802–813 (1988).
Urlaub, G., Mitchell, P.J., Ciudad, C.J. & Chasin, L.A. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Molec. Cell. Biol. 9, 2868–2880 (1989).
Fojo, S.S. et al. A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency. J. clin. Invest. 84, 1215–1219 (1989).
Cheng, J., Fogel-Petrovic, M. & Maquat, L.E. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate Isomerase mRNA. Molec. Cell. Biol. 10, 5215–5225 (1990).
Hamosh, A. et al. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J clin. Invest. 88, 1880–1885 (1991).
Mclntosh, I., Hamosh, A. & Dietz, H.C. Nonsense mutations and diminished mRNA levels. Nature Genet. 4, 219 (1993).
Sato, M. & Gitlin, J.D. Mechanisms of copper Incorporation during the biosynthesis of human Ceruloplasmin. J. biol. Chem. 266, 5128–6134 (1991).
Noyer, M. & Putnam, F.W. A circular dichroism study of undegraded human Ceruloplasmin. Biochemistry 20, 3536–3542 (1981).
Kingston, I.B., Kingston, B.L. & Putnam, F.W. Complete amino acid sequence of a histldine-rich proteolytlc fragment of human Ceruloplasmin. Proc. natn. Acad. Sci. U.S.A. 76, 1668–1672 (1979).
Kingston, I.B., Kingston, B.L. & Putnam, F.W. Primary structure of ahistldine rich proteolytic fragment of human Ceruloplasmin I. amino acid sequence of the cyanogen bromide peptides. J. biol. Chem. 255, 2878–2885 (1980).
Kingston, I.B., Kingston, B.L. & Putnam, F.W. Primary structure of ahlstldlne rich proteolytic fragment of human Ceruloplasmin II. amino acid sequence of the tryptic peptides. J. biol. Chem. 255, 2886–2896 (1980).
Kingston, I.B., Kingston, B.L. & Putnam, F.W. Chemical evidence that proteolytic cleavage causes the heterogeneity present in human Ceruloplasmin preparations. Proc. natn. Acad. Sci. U.S.A. 74, 5377–5381 (1977).
Rydén, L. Model of the active site in the blue oxidases based on the ceruloplasmin-plastocyanin homology. Proc. natn. Acad. Sci. U.S.A. 79, 6767–6771 (1982).
Osaki, S., Johnson, D.A. & Frieden, E. The possible significance of the ferrous oxidase activity of Ceruloplasmin in normal human serum. J. biol. Chem. 241, 2746–2751 (1966).
Lee, G.R., Nacht, S., Lukens, J.N. & Cartwright, G.E. Iron metabolism in copper-deficient swine. J. clin. Invest. 47, 2058–2069 (1968).
Ragan, H.A., Nacht, S., Lee, G.R., Bishop, C.R. & Cartwright, G.E. Effect of Ceruloplasmin on plasma iron in copper-deficient swine. Am. J. Physiol. 217, 1320–1323, (1969).
Roeser, H.P., Lee, G.R., Nacht, S. & Cartwright, G.E. The role of Ceruloplasmin in iron metabolism. J. clin. Invest. 49, 2408–2417 (1970).
Osaki, S., Johnson, D.A. & Frieden, E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. biol Chem. 246, 3018–3023 (1971).
Owen, C.A.Jr., Effects of iron on copper metabolism and copper on iron metabolism in rats. Am. J. Physiol. 224, 514–518 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, K., Furihata, K., Takeda, S. et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9, 267–272 (1995). https://doi.org/10.1038/ng0395-267
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0395-267
This article is cited by
-
Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation
Neurological Sciences (2022)
-
Looking for a partner: ceruloplasmin in protein–protein interactions
BioMetals (2019)
-
The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force
The Cerebellum (2019)
-
Copper chelation and interleukin-6 proinflammatory cytokine effects on expression of different proteins involved in iron metabolism in HepG2 cell line
BMC Biochemistry (2017)
-
Systematic review of autosomal recessive ataxias and proposal for a classification
Cerebellum & Ataxias (2017)